Hangzhou Alltest Biotech Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 11.88%

Hangzhou Alltest Biotech Co. Ltd. A (688606) has an Asset Resilience Ratio of 11.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688606 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥488.18 Million

≈ $71.44 Million USD Cash + Short-term Investments

Total Assets

CN¥4.11 Billion

≈ $601.28 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Hangzhou Alltest Biotech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688606 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Hangzhou Alltest Biotech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hangzhou Alltest Biotech Co. Ltd. A asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥488.18 Million	11.88%
Total Liquid Assets	CN¥488.18 Million	11.88%

Asset Resilience Insights

Moderate Liquidity: Hangzhou Alltest Biotech Co. Ltd. A has 11.88% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Hangzhou Alltest Biotech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Hangzhou Alltest Biotech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
SKAN Group AG SW:SKAN	Medical Instruments & Supplies	19.56%
Eyebright Medical Technology Beijing Co Ltd SHG:688050	Medical Instruments & Supplies	1.51%
Pegavision TW:6491	Medical Instruments & Supplies	17.14%
IVF Hartmann Holding AG SW:VBSN	Medical Instruments & Supplies	52.05%
I.Ceram SA PA:ALICR	Medical Instruments & Supplies	-1.61%
Safe Orthopaedics SA PA:ALSAF	Medical Instruments & Supplies	2.20%
Caina Technology Co. Ltd. SHE:301122	Medical Instruments & Supplies	19.55%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%

Annual Asset Resilience Ratio for Hangzhou Alltest Biotech Co. Ltd. A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Hangzhou Alltest Biotech Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.23%	CN¥1.32 Billion ≈ $193.87 Million	CN¥4.24 Billion ≈ $620.80 Million	-8.36pp
2024-12-31	39.59%	CN¥1.66 Billion ≈ $242.52 Million	CN¥4.19 Billion ≈ $612.55 Million	+3.85pp
2023-12-31	35.75%	CN¥1.47 Billion ≈ $215.31 Million	CN¥4.12 Billion ≈ $602.31 Million	-3.25pp
2022-12-31	39.00%	CN¥1.83 Billion ≈ $268.21 Million	CN¥4.70 Billion ≈ $687.72 Million	+19.54pp
2021-12-31	19.46%	CN¥780.20 Million ≈ $114.17 Million	CN¥4.01 Billion ≈ $586.55 Million	-16.59pp
2020-12-31	36.05%	CN¥415.00 Million ≈ $60.73 Million	CN¥1.15 Billion ≈ $168.44 Million	+17.41pp
2019-12-31	18.65%	CN¥62.00 Million ≈ $9.07 Million	CN¥332.50 Million ≈ $48.66 Million	--

pp = percentage points

About Hangzhou Alltest Biotech Co. Ltd. A

SHG:688606 China Medical Instruments & Supplies

Market Cap

$593.29 Million

CN¥4.05 Billion CNY

Market Cap Rank

#11393 Global

#3237 in China

Share Price

CN¥51.14

Change (1 day)

+0.08%

52-Week Range

CN¥41.00 - CN¥72.16

All Time High

CN¥121.60